Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
•
Neurogenetics
What factors do you consider when determining eligibility for hematopoietic stem cell therapies for metachromatic leukodystrophy?
Related Questions
Is there utility to ordering biochemical screening labs for global developmental delay?
When do you consider cannabidiol for treatment of epilepsy?
What are your preferred anti-seizure medications for Doose syndrome?
How do you discontinue ketogenic diets previously used as a treatment for epilepsy?
How do you counsel parents of patients with Autism Spectrum Disorder regarding the limitations of medications without engaging in behavioral or family interventions?
How would you approach a toddler with alternating head tilt episodes lasting for weeks?
Would you start antiseizure medications in tuberous sclerosis before seizure onset?
In a neonate with cerebral sinus venous thrombosis who is fluid-limited by renal or cardiac disease, do you recommend hyperhydration before anticoagulation?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
When is the most appropriate time to initiate evaluation for learning disorders following traumatic brain injury in an adolescent?
